CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), joins the show to discuss cancer therapy using cannabinoids, developing patient specific therapies, and the future of the medical cannabis industry.

OTCQB: CNBX # cannabinoid based cancer therapy # Israel # cancer patients # tumors # Anorexia # fully licensed # Liquid Biopsy # personalized diagnostic tools # practitioners and patients # tailored therapies